[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, et al
Proteases in the peritoneal fluid appear to degrade GLP-1 faster than normal, creating a pro-inflammatory environment where the natural braking mechanisms on inflammation are weakened
When uncertainty exists, biopsy provides definitive diagnosis and excludes melanoma
Research Insight: Clinical trials have consistently shown that GLP-1 receptor agonists lead to significant delays in gastric emptying, contributing directly to reduced food intake and weight loss
While response time varies, many patients notice improvements in gut health, recovery speed, or reduced inflammation within the first few weeks